New product aims to give CROs and sponsors a competitive advantage
goBalto, Inc., the leading provider of cloud-based clinical study startup solutions, announced today the release of Analyze, a reporting tool that provides a real-time view into clinical operations data.
With Analyze, study managers now gain deeper, instant insight into performance across accounts, portfolios, studies, countries, and sites. Users can also customize and share reports, internally and externally to members of partnering organizations. Customers can create new reports based on the standard ones available in Analyze, or build new, ad-hoc reports using an easy to use editing interface.
Analyze interacts seamlessly with goBalto’s flagship product, Activate, where information about sites, documents, submissions, milestones, and the status of activities related to them are tracked and managed. Analyze is also hosted in the cloud, so it can be accessed anytime and anywhere.
Analyze enables support for analytics by allowing you to instantly view status, quantify your team’s performance, and discover meaningful patterns in your clinical study startup data.
Recognizing that good data increasingly translates to a competitive advantage for its customers, goBalto built Analyze with the goals of simplicity, completeness, and flexibility. Customizable reports, drag and drop visualizations, and interactive dashboards allow decision makers to make faster, better decisions that improve performance and directly impact their clinical study startup conduct.
“Our customers were eager for a solution like Analyze,” said Andrea Sim, goBalto VP Product. “They’re already embracing all of the advantages that come with using Activate. Now, we’re providing them with the ability to gain even further insight into their study startup status, cycle times, and bottlenecks. Analyze is where big data meets and exceeds our customer’s needs.”
Truqap Combination Shines in Phase III Trial for Prostate Cancer
November 26th 2024Data from the CAPItello-281 trial show Truqap alongside abiraterone and androgen deprivation therapy achieved a statistically significant and clinically meaningful improvement in radiographic progression-free survival.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.